Choose date and time: ×
In the last half-hour
In the last 2 hours
In the last 4 hours
Earlier today
In the last 8 hours
A health-care warning Jimmy Kimmel should voice WorldNetDaily 22:01 24-Sep-17
Rs 996-cr package for SMEs in bulk drugs Deccan Herald 21:39 24-Sep-17
5 Things to Know About Epidural Steroid Injections Pain News Network 20:20 24-Sep-17
3 Monster Biotech Stocks in the Making The Motley Fool 14:18 24-Sep-17
Making The Grade Banker & Tradesman, Massachusetts 12:07 24-Sep-17
AbbVie's Unfazed by the Risk of Generic Humira The Motley Fool 12:07 24-Sep-17
Incyte - Not Buying The Dip Yet Seeking Alpha 10:57 24-Sep-17
3 Stocks With Nike-Like Return Potential The Motley Fool 01:23 24-Sep-17
Samsung Biologics to remain top drug firm by market cap Yonhap News Agency 01:02 24-Sep-17
In the last 7 days
Gene Therapy Is Nearing a Major Breakthrough Barron's Online 13:25 23-Sep-17
Biotech: The Big Payoff Seeking Alpha 12:35 23-Sep-17
Zydus Cadila gets USFDA nod to sell hypertension drug The Business Standard 11:23 23-Sep-17
Zydus Cadila gets USFDA nod to sell BP lowering drug The Hindu Business Line 10:53 23-Sep-17
US Pharma IPO Potential In Good Health Corporate Financing Week 08:13 23-Sep-17
Alzheimer’s Disease 05:03 23-Sep-17
Expect A Slow Bleed With Portola Pharma Seeking Alpha 22:45 22-Sep-17
U.S. FDA declines to approve J&J arthritis drug 22:10 22-Sep-17
U.S. FDA rejects J&J's arthritis drug 21:47 22-Sep-17
Why We Bought Gilead This Week Seeking Alpha 21:29 22-Sep-17
Metallopeptide catalyst eases synthesis of antibody-drug conjugates Chemical & Engineering News 21:09 22-Sep-17
Allergan Is A Bargain Seeking Alpha 20:57 22-Sep-17
Why Exelixis, Inc. Slumped Today The Motley Fool 20:05 22-Sep-17
Bibile Policy again: Quality drugs to be made in Sri L ... Sri Lanka Daily Mirror 19:36 22-Sep-17
Scientists grow bullish on pig-to-human transplants Science Magazine 19:09 22-Sep-17
Dow's drop defies broad market rally MarketWatch 19:01 22-Sep-17
Allergan Needs to Learn to Let Go Bloomberg 18:18 22-Sep-17
Oberoi Realty to buy GSK Pharma's Thane plot for Rs 555 cr The Business Standard 18:17 22-Sep-17

About our Pharma news...

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as pharma news might appear - please feel free to contact us regarding any persistent issues. [Read more]

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • This site uses cookies. To see how, read our Privacy and Cookie Notice. If you disagree with our use of cookies, please navigate away.
Sorry, no headlines or news topics were found. Please try different keywords.